Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(CSE:
DMED
)
0.0400
UNCHANGED
Streaming Delayed Price
Updated: 9:45 AM EDT, May 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DMED
< Previous
1
2
Next >
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
May 25, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
May 17, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
May 10, 2023
Focused on Health GenAI and CERVAI™, a generative AI brain health platform
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
May 03, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 22, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 14, 2023
CERVAI™ to be available in May 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
February 01, 2023
Brain Health Digital Platform to be available in May 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
January 31, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease
November 15, 2022
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.